Small Molecule Innovator API CDMO Market Size, Share & Trends Report

Small Molecule Innovator API CDMO Market Size, Share & Trends Analysis Report By Stage Type (Preclinical, Clinical, Commercial), By Customer Type (Pharmaceutical, Biotechnology), By Therapeutic Area, By Region, And Segment Forecasts, 2025 - 2030

Report ID: GVR-4-68040-250-0
Number of Report Pages: 150
Format: PDF

Historical Range: 2018 - 2023
Forecast Period: 2025 - 2030
Industry: Healthcare

Market Segmentation

Small Molecule Innovator API CDMO Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
- Preclinical
- Clinical
  - Phase I
  - Phase II
  - Phase III
- Commercial
Small Molecule Innovator API CDMO Work Flow Outlook (Revenue, USD Million, 2018 - 2030)
- Clinical
  - Small
  - Medium
  - Large
- Commercial
  - Small
  - Medium
  - Large
Small Molecule Innovator API CDMO Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
- Cardiovascular Diseases
- Oncology
- Respiratory Disorders
- Neurology
- Metabolic Disorders
- Infectious Diseases
- Others
Small Molecule Innovator API CDMO Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Small Molecule Innovator AIP CDMO Market, by Stage Type
    - Preclinical
    - Clinical
      - Phase I
      - Phase II
      - Phase III
    - Commercial
  - North America Small Molecule Innovator AIP CDMO Market, by Customer Type
    - Pharmaceutical
      - Small
      - Medium
      - Large
    - Commercial
      - Small
      - Medium
      - Large
  - North America Small Molecule Innovator AIP CDMO Market, by Therapeutic Area
    - Cardiovascular Diseases
    - Oncology
    - Respiratory Disorders
    - Neurology
    - Metabolic Disorders
    - Infectious Diseases
    - Others
  - U.S.
    - U.S. Small Molecule Innovator AIP CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - U.S. Small Molecule Innovator AIP CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - U.S. Small Molecule Innovator AIP CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Canada
    - Canada Small Molecule Innovator AIP CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Canada Small Molecule Innovator AIP CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - Canada Small Molecule Innovator AIP CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
- Europe
  - Europe Small Molecule Innovator AIP CDMO Market, by Stage Type
    - Preclinical
    - Clinical
      - Phase I
      - Phase II
      - Phase III
    - Commercial
  - Europe Small Molecule Innovator AIP CDMO Market, by Customer Type
    - Pharmaceutical
      - Small
      - Medium
      - Large
    - Biotechnology
      - Small
      - Medium
      - Large
  - Europe Small Molecule Innovator AIP CDMO Market, by Therapeutic Area
    - Cardiovascular Diseases
    - Oncology
    - Respiratory Disorders
    - Neurology
    - Metabolic Disorders
    - Infectious Diseases
    - Others
  - UK
    - UK Small Molecule Innovator AIP CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - UK Small Molecule Innovator AIP CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - UK Small Molecule Innovator AIP CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Germany
    - Germany Small Molecule Innovator AIP CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Germany Small Molecule Innovator AIP CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - Germany Small Molecule Innovator AIP CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - France
    - France Small Molecule Innovator AIP CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - France Small Molecule Innovator AIP CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - France Small Molecule Innovator AIP CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Italy
    - Italy Small Molecule Innovator AIP CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Italy Small Molecule Innovator AIP CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - Italy Small Molecule Innovator AIP CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Spain
    - Spain Small Molecule Innovator AIP CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Spain Small Molecule Innovator AIP CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - Spain Small Molecule Innovator AIP CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Denmark
    - Denmark Small Molecule Innovator AIP CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Denmark Small Molecule Innovator AIP CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - Denmark Small Molecule Innovator AIP CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Sweden
    - Sweden Small Molecule Innovator AIP CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Sweden Small Molecule Innovator AIP CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - Sweden Small Molecule Innovator AIP CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Norway
    - Norway Small Molecule Innovator AIP CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Norway Small Molecule Innovator AIP CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - Norway Small Molecule Innovator AIP CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
- Asia Pacific
  - Asia Pacific Small Molecule Innovator AIP CDMO Market, by Stage Type
    - Preclinical
    - Clinical
      - Phase I
      - Phase II
      - Phase III
    - Commercial
  - Asia Pacific Small Molecule Innovator AIP CDMO Market, by Customer Type
    - Pharmaceutical
      - Small
      - Medium
      - Large
    - Biotechnology
      - Small
      - Medium
      - Large
  - Asia Pacific Small Molecule Innovator AIP CDMO Market, by Therapeutic Area
    - Cardiovascular Diseases
    - Oncology
    - Respiratory Disorders
    - Neurology
    - Metabolic Disorders
    - Infectious Diseases
    - Others
  - China
    - China Small Molecule Innovator AIP CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - China Small Molecule Innovator AIP CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - China Small Molecule Innovator AIP CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Japan
    - Japan Small Molecule Innovator AIP CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Japan Small Molecule Innovator AIP CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - Japan Small Molecule Innovator AIP CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - India
    - India Small Molecule Innovator AIP CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - India Small Molecule Innovator AIP CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - India Small Molecule Innovator AIP CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Australia
    - Australia Small Molecule Innovator AIP CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Australia Small Molecule Innovator AIP CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - Australia Small Molecule Innovator AIP CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - South Korea
    - South Korea Small Molecule Innovator AIP CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - South Korea Small Molecule Innovator AIP CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - South Korea Small Molecule Innovator AIP CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Thailand
    - Thailand Small Molecule Innovator AIP CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Thailand Small Molecule Innovator AIP CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - Thailand Small Molecule Innovator AIP CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Taiwan
    - Taiwan Small Molecule Innovator AIP CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Taiwan Small Molecule Innovator AIP CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - Taiwan Small Molecule Innovator AIP CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
- Latin America
  - Latin America Small Molecule Innovator AIP CDMO Market, by Stage Type
    - Preclinical
    - Clinical
      - Phase I
      - Phase II
      - Phase III
    - Commercial
  - Latin America Small Molecule Innovator AIP CDMO Market, by Customer Type
    - Pharmaceutical
      - Small
      - Medium
      - Large
    - Biotechnology
      - Small
      - Medium
      - Large
  - Latin America Small Molecule Innovator AIP CDMO Market, by Therapeutic Area
    - Cardiovascular Diseases
    - Oncology
    - Respiratory Disorders
    - Neurology
    - Metabolic Disorders
    - Infectious Diseases
    - Others
  - Brazil
    - Brazil Small Molecule Innovator AIP CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Brazil Small Molecule Innovator AIP CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - Brazil Small Molecule Innovator AIP CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Mexico
    - Mexico Small Molecule Innovator AIP CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Mexico Small Molecule Innovator AIP CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - Mexico Small Molecule Innovator AIP CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Argentina
    - Argentina Small Molecule Innovator AIP CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Argentina Small Molecule Innovator AIP CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - Argentina Small Molecule Innovator AIP CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
- Middle East and Africa
  - Middle East and Africa Small Molecule Innovator AIP CDMO Market, by Stage Type
    - Preclinical
    - Clinical
      - Phase I
      - Phase II
      - Phase III
    - Commercial
  - Middle East and Africa Small Molecule Innovator AIP CDMO Market, by Customer Type
    - Pharmaceutical
      - Small
      - Medium
      - Large
    - Biotechnology
      - Small
      - Medium
      - Large
  - Middle East and Africa Small Molecule Innovator AIP CDMO Market, by Therapeutic Area
    - Cardiovascular Diseases
    - Oncology
    - Respiratory Disorders
    - Neurology
    - Metabolic Disorders
    - Infectious Diseases
    - Others
  - South Africa
    - South Africa Small Molecule Innovator AIP CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - South Africa Small Molecule Innovator AIP CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - South Africa Small Molecule Innovator AIP CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Saudi Arabia
    - Saudi Arabia Small Molecule Innovator AIP CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Saudi Arabia Small Molecule Innovator AIP CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - Saudi Arabia Small Molecule Innovator AIP CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - UAE
    - UAE Small Molecule Innovator AIP CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - UAE Small Molecule Innovator AIP CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - UAE Small Molecule Innovator AIP CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Kuwait
    - Kuwait Small Molecule Innovator AIP CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Kuwait Small Molecule Innovator AIP CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - Kuwait Small Molecule Innovator AIP CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Israel
    - Israel Small Molecule Innovator AIP CDMO Market, by Stage Type
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Israel Small Molecule Innovator AIP CDMO Market, by Customer Type
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Biotechnology
        
        Small
        
        Medium
        
        Large
    - Israel Small Molecule Innovator AIP CDMO Market, by Therapeutic Area
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.